Rational combinations of immunotherapeutics that target discrete pathways
Author:
Publisher
BMJ
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy
Link
http://link.springer.com/content/pdf/10.1186/2051-1426-1-16.pdf
Reference141 articles.
1. Burnet FM: Cancer—a biological approach: I. The processes of control. II. The significance of somatic mutation. Brit Med J. 1957, 1: 779-786. 10.1136/bmj.1.5022.779.
2. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD: Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002, 3: 991-998. 10.1038/ni1102-991.
3. Dighe AS, Richards E, Old LJ, Schreiber RD: Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity. 1994, 1: 447-456. 10.1016/1074-7613(94)90087-6.
4. Ikeda H, Old LJ, Schreiber RD: The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 2002, 13: 95-109. 10.1016/S1359-6101(01)00038-7.
5. Penn I: Malignant Tumors in Organ Transplant Recipients. Recent Results in Cancer, Volume 35. 1970, Heidelberg: Springer-Verlag, 1-55.
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. IL2RA is a prognostic indicator and correlated with immune characteristics of pancreatic ductal adenocarcinoma;Medicine;2022-10-21
2. Immunotherapy in the complex treatment of tumor diseases;Siberian journal of oncology;2022-05-08
3. A Novel Oral Arginase 1/2 Inhibitor Enhances the Antitumor Effect of PD-1 Inhibition in Murine Experimental Gliomas by Altering the Immunosuppressive Environment;Frontiers in Oncology;2021-08-24
4. Treatment of Advanced Melanoma in 2020 and Beyond;Journal of Investigative Dermatology;2021-01
5. Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy;Cancers;2020-12-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3